PRADAXA (DABIGATRAN EXTILATE) has been heavily promoted and advertised in mass media outlets, including the Internet, TV and print. This promotional video was posted to YouTube in November 2011 as reports were just emerging of over 260 deaths world wide. At the time, reports appeared to indicate that the number of anticipated deaths may have been underestimated by representatives of the manufacturer, BOEHRINGER INGELHEIM. Since that time, the U.S. Food & Drug Administration has publicly noted that it is monitoring post-approval (October 2010) reports of bleeding associated with PRADAXA CASES.
(Source: pradaxacases.com)
